| Ident. | Authors (with country if any) | Title |
|---|
| 000030 (2017) |
Vincent Meininger [France] ; Angela Genge [Canada] ; Leonard H. Van Den Berg [Pays-Bas] ; Wim Robberecht [Belgique] ; Albert Ludolph [Allemagne] ; Adriano Chio [Italie] ; Seung H. Kim [Corée du Sud] ; P Nigel Leigh [Royaume-Uni] ; Matthew C. Kiernan [Australie] ; Jeremy M. Shefner [États-Unis] ; Claude Desnuelle [France] ; Karen E. Morrison [Royaume-Uni] ; Susanne Petri [Allemagne] ; Diane Boswell [Royaume-Uni] ; Jane Temple [Royaume-Uni] ; Rajat Mohindra [Royaume-Uni] ; Matt Davies [Royaume-Uni] ; Jonathan Bullman [Royaume-Uni] ; Paul Rees [Royaume-Uni] ; Arseniy Lavrov [Royaume-Uni] | Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. |
| 000232 (2016) |
Panying Rong [États-Unis] ; Yana Yunusova [Canada] ; Jun Wang [États-Unis] ; Lorne Zinman [Canada] ; Gary L. Pattee [États-Unis] ; James D. Berry [États-Unis] ; Bridget Perry [États-Unis] ; Jordan R. Green [États-Unis] | Predicting Speech Intelligibility Decline in Amyotrophic Lateral Sclerosis Based on the Deterioration of Individual Speech Subsystems |
| 000423 (2016) |
Eiichiro Nagata [Japon] ; Mieko Ogino [Japon] ; Kounosuke Iwamoto [Japon] ; Yasuhisa Kitagawa [Japon] ; Yasuo Iwasaki [Japon] ; Fumihito Yoshii [Japon] ; Joh-E. Ikeda [Japon, Canada] | Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients |
| 000589 (2015) |
Hiroshi Mitsumoto ; Peter L. Nagy ; Chris Gennings ; Jennifer Murphy ; Howard Andrews ; Raymond Goetz ; Mary Kay Floeter ; Jonathan Hupf ; Jessica Singleton ; Richard J. Barohn ; Sharon Nations ; Christen Shoesmith ; Edward Kasarskis ; Pam Factor-Litvak | Phenotypic and molecular analyses of primary lateral sclerosis |
| 000741 (2015) |
Sanjana Shellikeri [Canada] ; Yana Yunusova [Canada] ; Jordan R. Green [États-Unis] ; Gary L. Pattee [États-Unis] ; James D. Berry [États-Unis] ; Seward B. Rutkove [États-Unis] ; Lorne Zinman [Canada] | Electrical Impedance Myography (EIM) in the Evaluation of the Tongue Musculature in Amyotrophic Lateral Sclerosis (ALS) |
| 000841 (2015) |
John C. Steele ; Robert Wresch [États-Unis] ; Samuel D. Hanlon [États-Unis] ; Jay Keystone [Canada] ; Yoav Ben-Shlomo [Royaume-Uni] | A unique retinal epitheliopathy is associated with amyotrophic lateral sclerosis/Parkinsonism-Dementia complex of Guam. |
| 000B80 (2014) |
Alexandro Gianforcaro [Canada] ; Mazen J. Hamadeh [Canada] | Vitamin D as a Potential Therapy in Amyotrophic Lateral Sclerosis |
| 000F23 (2013) |
Serena Lattante [France] ; Guy A. Rouleau [Canada] ; Edor Kabashi [France, Canada] | TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update |
| 001291 (2012) |
Adrian Baranchuk [Canada] ; Riyaz Somani ; Christopher S. Simpson ; Kevin A. Michael ; Damian P. Redfearn | Ablation of a left lateral accessory pathway in a patient with dextroposition of the heart. |
| 002040 (2009) |
M. M. Lewis [États-Unis] ; A. B. Smith [États-Unis] ; M. Styner [États-Unis] ; H. Gu [États-Unis] ; R. Poole [États-Unis] ; H. Zhu [États-Unis] ; Y. Li [États-Unis] ; X. Barbero [États-Unis] ; S. Gouttard [États-Unis] ; M. J. Mckeown [Canada] ; R. B. Mailman [États-Unis] ; X. Huang [États-Unis] | Asymmetrical lateral ventricular enlargement in Parkinson’s disease |
| 002042 (2009) |
Andrew Eisen [Canada] | Amyotrophic lateral sclerosis—Evolutionary and other perspectives |
| 002199 (2008) |
Judith Miklossy [Canada] ; John C. Steele ; Sheng Yu ; Sherman Mccall ; Glenn Sandberg ; Edith G. Mcgeer ; Patrick L. Mcgeer | Enduring involvement of tau, beta-amyloid, alpha-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam (ALS/PDC). |
| 002543 (2007) |
Edor Kabashi [Canada] ; Paul N. Valdmanis [Canada] ; Patrick Dion [Canada] ; Guy A. Rouleau [Canada] | Oxidized/misfolded superoxide dismutase‐1: the cause of all amyotrophic lateral sclerosis? |
| 002B55 (2004) |
Harold D. Foster [Canada] ; Abram Hoffer | The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis. |
| 002C68 (2004) |
Claudia L. R. Gonzalez [Canada] ; Omar A. Gharbawie [Canada] ; Preston T. Williams [Canada] ; Jeffrey A. Kleim [Canada] ; Bryan Kolb [Canada] ; Ian Q. Whishaw [Canada] | Evidence for bilateral control of skilled movements: ipsilateral skilled forelimb reaching deficits and functional recovery in rats follow motor cortex and lateral frontal cortex lesions |
| 003480 (2000) |
Ida Tonolli [France] ; Roselyne Aurenty [France] ; Robert George Lee [France, Canada] ; François Viallet [France] ; Jean Massion [France] | Lateral leg raising in patients with Parkinson's disease: Influence of equilibrium constraint |
| 003842 (1999) |
V. Radhakrishnan [Canada] ; J. Tsoukatos [Canada] ; K. D. Davis [Canada] ; R. R. Tasker [Canada] ; A. M. Lozano [Canada] ; J. O. Dostrovsky [Canada] | A comparison of the burst activity of lateral thalamic neurons in chronic pain and non-pain patients |
| 003857 (1998) |
D. Parkinson [Canada] | Lateral sellar compartment O.T. (cavernous sinus): history, anatomy, terminology. |
| 003C58 (1997) |
P. L. Mcgeer [Canada] ; C. Schwab [Canada] ; E. G. Mcgeer [Canada] ; R. L. Haddock ; J. C. Steele | Familial nature and continuing morbidity of the amyotrophic lateral sclerosis-parkinsonism dementia complex of Guam |
| 004302 (1994) |
P. J. Blanchet [Canada] ; R. Boucher [Canada] ; P. J. Bedard | Excitotoxic lateral pallidotomy does not relieve L-DOPA-induced dyskinesia in MPTP parkinsonian monkeys |
| 004395 (1993) |
Jing Kremer [Pays-Bas] ; G. Th. A. M. Bots [Pays-Bas] | Lewy bodies in the lateral hypothalamus: Do they imply neuronal loss? |
